Marc Better, VP, Product Sciences at Kite Pharma, Inc. (KITE), sold 9,000 shares at $68.22 ($640K) on 2015-11-02, disclosed to the SEC on 2015-11-04.
Scheduled sale ($640k) by VP, Product Sciences under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.22 | 590 | $40K | 6.3% |
| 2 | $69.81 | 525 | $37K | 5.7% |
| 3 | $70.87 | 2,876 | $204K | 31.9% |
| 4 | $71.64 | 4,899 | $351K | 54.9% |
| 5 | $72.41 | 110 | $8K | 1.2% |
| Total | $71.07 avg | 9,000 |
| $640K |
| 100% |
| Filing → |
| KITE | SELL | 2015-12-03 | $687K | — | Filing → |
| KITE | SELL | 2015-10-02 | $493K | — | Filing → |
| KITE | SELL | 2015-09-03 | $466K | — | Filing → |